Hims & Hers Health (HIMS) stock
Last close $16.02 on 2026-11-19 (-6.04%) · Sector: Consumer Defensive
Hims & Hers Health is a U.S. online health company that sells wellness products, including prescription treatments for hair loss, sexual wellness products, and skincare. Customers mostly order through its website and app, and the company earns money from product sales and recurring subscriptions.
The business is growing, with revenue up 29.9% over the past year and quarterly sales reaching $0.89 billion in the latest period. However, profit has turned negative, with the latest quarter showing an operating loss, meaning costs are higher than what the company brings in from its operations. The stock has fallen 52.3% over the past year while the S&P 500 rose 9.7%, so it has trailed the broader market. Shares have dropped after each of the last four earnings reports, and insiders sold $3.1 million of stock over the past 90 days with no insider buys.
Key numbers
- Market cap: $3.7B
- Revenue (last 12 months): $2.87B
- Revenue growth: +29.9%
- Gross margin: 64.5%
- Operating margin: -8.4%
- P/S: 1.3
- Debt to equity: 0.00
- Current ratio: 0.92
Quality score
Overall 44/100 · growth 54 · profitability 10 · financial health 67 · value None
Performance and risk
1-year return -52.3% vs S&P 500 +9.7% · volatility 93.1% (S&P 500 13.8%) · largest drop -63.7% · beta 2.64
Stock move the day after earnings
- 2026-02-23: -0.3%
- 2026-05-11: -14.1%
- 2026-08-10: -4.0%
- 2026-11-09: -16.6%
Insider trades (12 months)
Bought $1.2M · sold $19.2M
HIMS stock research · HIMS options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.